Finzati - Logo
PRVA logo

Privia Health Group, Inc.

PRVA • Medical - Healthcare Information Services
$0.00
— 0.00 (0.00%)
EarningsLatest report: Jun 30, 2026
BALANCED PROFILENeutralConfidence: 70%

Quantitative profile — not an investment recommendation.

Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Mixed profile. The company is not automatically unattractive, but valuation, growth, or balance-sheet evidence does not yet justify a stronger signal.
Market Cap
$2.77B
Growth
15.3%
Cash Flow
5/5
Trend
Stable
Evidence
Positive revenue growth · 18.0%Positive free cash flow · 1.33Consistent free cash flow · 5/5Manageable debt level · 0.01Healthy liquidity · 1.6
Financial data as of: Jun 30, 2026, 12:00 AM UTCLast earnings update: Jun 30, 2026, 12:00 AM UTCLast profile update: Aug 7, 2026, 12:56 PM UTC

Company Snapshot

Key valuation, quality, financial strength, momentum and analyst data.

Price$0.00
Change0.00%
Market Cap$2.77B
52W Range19.08 - 28.82
Beta0.84
Gross Margin9.87%
Oper. Margin1.61%
Profit Margin1.08%
Debt/Eq0.01
Current Ratio1.60
Quick Ratio1.60
Revenue 5Y15.34%

Investment DNA

How strong this company looks for long-term investors

67
out of 100
Business Quality
Margins, moat, returns
40/100
Financial Strength
Debt, cash, stability
73/100
Growth Potential
Revenue and expansion
95/100
Price Attractiveness
Cheap or expensive today
56/100
Why this score▼
Positive revenue growth · 18.0%Positive free cash flow · 1.33Consistent free cash flow · 5/5Manageable debt level · 0.01Healthy liquidity · 1.6Expensive earnings multiple · 126.39

Analyst view

Analyst sentiment and price target

Analyst sentiment
No vote count available
Bullish
0
Hold
0
Bearish
0
Price Target
2026-08-07
Low
$24.00
Mean
$29.50
Median
$29.00
High
$36.00

Company Overview

IPO: 4/28/2021
Industry: Medical - Healthcare Information Services
P/B i: 3.93
Debt / Equity i: 0.01
Operating Margin: 1.61%
Net Margin: 1.08%
ROE i: -
ROIC: -

Financial Health

Score15 / 20
Debt / Equity: 0.01
Current Ratio: 1.60
Quick Ratio: 1.60
Status: Good

Insider Transactions

Recent executive and insider activity

Mountcastle David
Transaction: 07/09/2026
SELL
Change
-21,275
Price
$27.67
Filing
07/13/2026
Type
SELL
Mountcastle David
Transaction: 07/07/2026
SELL
Change
-600
Price
$27.57
Filing
07/09/2026
Type
SELL
Morris Matthew Shawn
Transaction: 07/06/2026
SELL
Change
-53,722
Price
$27.24
Filing
07/07/2026
Type
SELL